Membrane lipids and nuclear DNA are differently susceptive to Fenton reaction substrates in porcine thyroid

Toxicology in Vitro

Volumn 27, Issue 1, 2013, Pages 71-78

  Stepniak, Jan ^a   Lewiński, Andrzej ^a,b   Karbownik Lewińska, Małgorzata ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

DNA damage; Ferrous ion; Hydrogen peroxide; Lipid peroxidation; Thyroid

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CELL NUCLEUS DNA; FERROUS SULFATE; HYDROGEN PEROXIDE; MALONALDEHYDE; MEMBRANE LIPID;

ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DAMAGE; EXPERIMENTAL PIG; FENTON REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TIME; LIPID PEROXIDATION; MACROMOLECULE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; SPECTROPHOTOMETRY; THYROID GLAND; TISSUE HOMOGENATE; TOXICITY TESTING;

ANIMALS; DEOXYGUANOSINE; DNA; HYDROGEN PEROXIDE; IRON; LIPID PEROXIDATION; MEMBRANE LIPIDS; SWINE; THYROID GLAND;

SUS;

EID: 84869459785     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.09.010     Document Type: Article

References (44)

1. Akhtar M.J., Kumar S., Murthy R.C., Ashquin M., Khan M.I., Patil G., Ahmad I. The primary role of iron-mediated lipid peroxidation in the differential cytotoxicity caused by two varietes of talc nanoparticles on A549 cells and lipid peroxidation inhibitory effect exerted by ascorbic acid. Toxicol. in Vitro 2010, 24:1139-1147.
2. Ambrozova G., Pekarova M., Lojek A. The effect of lipid peroxidation products on reactive oxygen species formation and nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 macrophages. Toxicol. in Vitro 2011, 25. 152-152.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
4. Cabrera J., Burkhardt S., Tan D.X., Manchester L.C., Karbownik M., Reiter R.J. Autoxidation and toxicant-induced oxidation of lipid and DNA in monkey liver: reduction of molecular damage by melatonin. Pharmacol. Toxicol. 2001, 89:225-230.
5. Coclet J., Foureau F., Ketelbant P., Galand P., Dumont J.E. Cell population kinetics in dog and human adult thyroid. Clin. Endocrinol. (Oxf) 1989, 31:655-665.
6. Detours V., Delys L., Libert F., Weiss Solís D., Bogdanova T., Dumont J.E., Franc B., Thomas G., Maenhaut C. Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Br. J. Cancer 2007, 97:818-825.
7. Driessens N., Versteyhe S., Ghaddhab C., Burniat A., De Deken X., Van Sande J., Dumont J.E., Miot F., Corvilain B. Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ. Endocr. Relat. Cancer 2009, 16:845-856.
8. Duntas L.H. The role of selenium in thyroid autoimmunity and cancer. Thyroid 2006, 16:455-460.
9. Gitto E., Tan D.X., Reiter R.J., Karbownik M., Manchester L.C., Cuzzocrea S., Fulia F., Barberi I. Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates. J. Pharm. Pharmacol. 2001, 53:1393-1401.
10. Goetz M.E., Luch A. Reactive species: a cell damaging rout assisting to chemical carcinogens. Cancer Lett. 2008, 266:73-83.
11. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr. Rev. 2012, 70:257-265.
12. IARC monographs on the evaluation of carcinogenic risks to humans. Polynuclear aromatic compounds, part 3: industrial exposures in aluminium production, coal gasification, coke production, and iron and steel founding. Lyon: IARC, 1984; vol. 34, (Suppl. 7).
13. Karbownik M., Reiter R.J., Garcia J.J., Tan D. Melatonin reduces phenylhydrazine-induced oxidative damage to cellular membranes: evidence for the involvement of iron. Int. J. Biochem. Cell Biol. 2000, 32:1045-1054.
14. Karbownik M., Gitto E., Lewiński A., Reiter R.J. Relative efficacies of indole antioxidants in reducing autoxidation and iron-induced lipid peroxidation in hamster testes. J. Cell. Biochem. 2001, 81:693-699.
15. Karbownik M., Lewiński A., Reiter R.J. Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. Int. J. Biochem. Cell Biol. 2001, 33:735-753.
16. Karbownik M., Lewiński A. Melatonin reduces Fenton-induced lipid peroxidation in porcine thyroid tissue. J. Cell. Biochem. 2003, 90:806-811.
17. Karbownik M., Lewiński A. The role of oxidative stress in physiological and pathological processes in the thyroid gland; possible involvement in pineal-thyroid interactions. Neuro. Endocrinol. Lett. 2003, 24:293-303.
18. Karbownik-Lewińska, M., Stepniak, J., Szosland, J., Zasada, K., Lewiński, A., 2008. External hydrogen peroxide is indispensible for experimental induction of lipid peroxidation via Fenton reaction in porcine thyroid homogenates. 33rd Annual Meeting of the European Thyroid Association 20-24.09.2008, Thessaloniki-Chalkidiki, Greece, Hormones 7 (Suppl. 1), 69.
19. Karbownik-Lewińska M., Stepniak J., Krawczyk J., Zasada K., Szosland J., Gesing A., Lewiński A. External hydrogen peroxide is not indispensable for experimental induction of lipid peroxidation via Fenton reaction in porcine ovary homogenates. Neuro. Endocrinol. Lett. 2010, 31:343-347.
20. Klenow S., Pool-Zobel B.L., Glei M. Influence of inorganic and organic iron compounds on parameters of cell growth and survival in human colon cells. Toxicol. in Vitro 2009, 23:400-407.
21. Koduru B., Tejaswini, Thakur A., Kamath S.U., Shenoy K.R., Kamath U., Reshma K. Indicators of oxidative stress in thyroid cancer Indian. J. Biochem. Biophys. 2010, 47:121-123.
22. Kovacic P., Edwards C. Integrated approach to the mechanisms of thyroid toxins: electron transfer, reactive oxygen species, oxidative stress, cell signaling, receptors, and antioxidants. J. Recept. Signal Transduction Res. 2010, 30:133-142.
23. Köhrle J., Gärtner R. Selenium and thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 2009, 23:815-827.
24. Lacroix L., Nocera M., Mian C., Caillou B., Virion A., Dupuy C., Filetti S., Bidart J.M., Schlumberger M. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Thyroid 2001, 11:1017-1023.
25. Lau A.T., Wang Y., Chiu J.F. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J. Cell. Biochem. 2008, 104:657-667.
26. Liu X.H., Chen G.G., Vlantis A.C., van Hasselt C.A. Iodine mediated mechanisms and thyroid carcinoma. Crit. Rev. Clin. Lab. Sci. 2009, 46:302-318.
27. Lu N., Chen W., Zhu J., Peng Y.Y. Enhancement of nitrite on heme-induced oxidative reactions: a potential toxicological implication. Toxicol. in Vitro 2012, 26:81-85.
28. Mehta R., Dedina L., O'Brien P.J. Rescuing hepatocytes from iron-catalyzed oxidative stress using vitamins B1 and B6. Toxicol. in Vitro 2011, 25:1114-1122.
29. Natoli M., Felsani A., Ferruzza S., Sambuy Y., Canali R., Scarino M.L. Mechanisms of defence from Fe(II) toxicity in human intestinal Caco-2 cells. Toxicol. in Vitro 2009, 23:1510-1515.
30. Qi W., Reiter R.J., Tan D.X., Garcia J.J., Manchester L.C., Karbownik M., Calvo J.R. Chromium(III)-induced 8-hydroxydeoxyguanosine in DNA and its reduction by antioxidants: comparative effects of melatonin, ascorbate, and vitamin E. Environ. Health Perspect. 2000, 108:399-402.
31. Pellegriti G., De Vathaire F., Scollo C., Attard M., Giordano C., Arena S., Dardanoni G., Frasca F., Malandrino P., Vermiglio F., Previtera D.M., D'Azzò G., Trimarchi F., Vigneri R. Papillary thyroid cancer incidence in the volcanic area of Sicily. J. Natl. Cancer Inst. 2009, 101:1575-1583.
32. Poncin S., Gérard A.C., Boucquey M., Senou M., Calderon P.B., Knoops B., Lengelé B., Many M.C., Colin I.M. Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 2008, 149:424-433.
33. Poncin S., Van Eeckoudt S., Humblet K., Colin I.M., Gérard A.C. Oxidative stress: a required condition for thyroid cell proliferation. Am. J. Pathol. 2010, 176:1355-1363.
34. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012, 24:981-990.
35. Schröder E., Eaton P. Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations. Curr. Opin. Pharmacol. 2008, 8:153-159.
36. Schweitzer U., Chiu J., Köhrle J. Peroxides and peroxide-degrading enzymes in the thyroid. Antioxid Redox Signal. 2008, 10:1577-1592.
37. Sedelnikova O.A., Redon C.E., Dickey J.S., Nakamura A.J., Georgakilas A.G., Bonner W.M. Role of oxidatively induced DNA lesions in human pathogenesis. Mutat. Res. 2010, 704:152-159.
38. Shigenaga M.K., Aboujaoude E.N., Chen Q., Ames B.N. Assays of oxidative DNA damage biomarkers 8-oxo-2'-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 1994, 234:16-33.
39. Smyth P.P. Role of iodine in antioxidant defence in thyroid and breast disease. BioFactors 2003, 19:121-130.
40. Song Y., Driessens N., Costa M., De Deken X., Detours V., Corvilain B., Maenhaut C., Miot F., Van Sande J., Many M.C., Dumont J.E. Roles of hydrogen peroxide in thyroid physiology and disease. J. Clin. Endocrinol. Metab. 2007, 92:3764-3773.
41. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
42. Xing M. Oxidative stress: a new risk factor for thyroid cancer. Endocr. Relat. Cancer 2012, 9:C7-11.
43. Young O., Crotty T., O'Connell R., O'Sullivan J., Curran A.J. Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck 2010, 32:750-756.
44. Ziech D., Franco R., Pappa A., Panayiotidis M.I. Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat. Res. 2011, 711:167-173.